[ALA] YoY Quarter Result on 30-Sep-2020 [#Q1]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
29-Sep-2020
Financial Year
2021
Quarter
30-Sep-2020 [#Q1]
Profit Trend
QoQ- 60.91%
YoY- 77.30%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 972 714 11 176 192 427 202 29.91%
PBT -1,973 -1,950 -1,975 -874 -3,850 -435 -1,113 10.00%
Tax 0 0 0 0 0 0 0 -
NP -1,973 -1,950 -1,975 -874 -3,850 -435 -1,113 10.00%
Tax Rate - - - - - - - -
Total Cost 2,945 2,664 1,986 1,050 4,041 862 1,315 14.37%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -203.01 -272.98 -17,484.01 -496.92 -2,008.97 -101.83 -551.87 -15.34%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.00 -0.00 -0.00 -0.00 -0.03 -0.00 -0.02 -
EPS Diluted -0.00 -0.00 -0.00 -0.00 -0.03 -0.00 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.